Rechercher | SocialyTime

Aryan Mhatre Ajouter une nouvelle offre d'emploi Art
2026-01-05 12:53:01 -

Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights
"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...

0 Commentaires 0 Parts 4KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Oddway Pharmaceutical Exporter Ajouter une nouvelle offre d'emploi Health
2026-04-24 10:07:48 -

Authentic Gefitinib Tablets IP 250 mg Exporter in Quezon City
The Philippines requires effective cancer treatment access because Gefitinib Tablets IP 250 mg serve as an important component of targeted therapy. The healthcare industry uses these Gefitinib Tablets because they deliver dependable results which make them suitable for extended treatment needs of patients and their medical teams. Many individuals select Gefitinib Tablets IP 250 mg because they...

1

0 Commentaires 0 Parts 21 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra Ajouter une nouvelle offre d'emploi Autre
2026-04-15 11:50:13 -

Brigatinib API Market Growing at 8.1% CAGR Through 2034 Globally
According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...

0 Commentaires 0 Parts 304 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra Ajouter une nouvelle offre d'emploi Autre
2026-04-22 10:26:21 -

Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034
According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...

0 Commentaires 0 Parts 110 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra Ajouter une nouvelle offre d'emploi Autre
2026-04-20 11:24:49 -

Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034
According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...

0 Commentaires 0 Parts 148 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra Ajouter une nouvelle offre d'emploi Autre
2026-04-13 12:30:06 -

Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034
According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...

0 Commentaires 0 Parts 276 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Oddway Pharmaceutical Exporter Ajouter une nouvelle offre d'emploi Health
2026-04-22 08:42:22 -

Reliable Gefitinib Tablets IP 250 mg Source in the Philippines
Doctors use Gefitinib Tablets IP 250 mg when treating non-small cell lung cancer because the drug specifically targets cancer cells. The Philippine healthcare system requires dependable oncology medications which Gefitinib Tablets IP 250 mg provide to deliver successful treatment results. Healthcare professionals and patients depend on Gefitinib Tablets because it provides them with needed...

1

0 Commentaires 0 Parts 69 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Oddway Pharmaceutical Exporter Ajouter une nouvelle offre d'emploi Health
2026-04-11 07:58:15 -

Trusted Gefitinib Tablets Exporter Philippines - Oddway
Healthcare professionals throughout the Philippines use Gefitinib Tablets as their standard treatment option for non-small cell lung cancer. The consistent availability and high quality of Gefitinib Tablets enable effective cancer treatment at medical facilities. The available Gefitinib Tablets IP 250 mg offer patients an easy way to take their medication through oral administration. The...

1

0 Commentaires 0 Parts 262 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!